Francis Capital Management LLC 13D and 13G filings for Aridis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 2:09 pm Sale | 2021-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Francis Capital Management LLC | 142,838 1.000% | -534,021![]() (-78.90%) | Filing |
2021-04-01 4:50 pm Purchase | 2021-03-17 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Francis Capital Management LLC | 676,859 6.100% | 676,859![]() (New Position) | Filing |